Föreläsningar och seminarier Biomarker-driven precision medicine: Industry-Academia Collaborations Seminar Series by Cancer Research KI and LIF
Cancer Research KI launched a seminar series on Industrial Collaboration, where we discuss topics such as legal issues, commission, collaboration but also there will be a chance to get inspired by researchers, who have already collaborated with the industry.
Cancer Research KI and LIF (The Swedish Association of the Pharmaceutical Industry) welcome you to a joint seminar on Biomarker-driven precision medicine which will be followed by an after-work event with drinks.
LIF is the trade association for the research-based pharmaceutical industry in Sweden. LIF has about 90 member companies, including AstraZeneca, GlaxoSmithKline, IQVIA, Ipsen, Merck, Roche and many more. The full list of member companies can be found here.
Date and Time: 4th of December 2024, 15:00-17:00h followed by AW
Location: Ragnar Granit, Biomedcium, Solna Campus
Registration: Please register by filling in the following form.
Agenda:
15.00-15.05 Welcome and introduction by Simon Ekman
15.05-15.25 Frida Lundmark from LIF: What is needed to move your project into the translational step.
15.25-16.00 Janne Lehtiö: Biomarker discovery
16.00-16.20 LIF pharma company Representative Sandra Eketorp Sylvan, Medical Director of Amgen: What is needed to move your project into clinical trial
16.20-17.00 Jeffrey Yachnin: Clinical trials
17:00-21:00 after-work with drinks and snacks
After-work Location: in the Biomedicum Faculty club on floor 10.